Pentaone Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.50 Cr
as on 16-11-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.33 Cr
as on 16-11-2024
- Revenue 1217.27%
(FY 2023)
- Profit -7588.21%
(FY 2023)
- Ebitda 1108.50%
(FY 2023)
- Net Worth -2062.56%
(FY 2023)
- Total Assets 63.39%
(FY 2023)
About Pentaone Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹2.33 Cr.
Anil Gupta, Asha Gupta, Sunil Gupta, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110OR2021PTC036797
- Company No.
036797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pentaone Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Agarwal  | Managing Director | 25-Jun-2021 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Gupta | Director | 25-Jun-2021 | Current |
| Asha Gupta | Director | 25-Jun-2021 | Current |
| Sunil Gupta | Director | 01-Oct-2024 | Current |
| Mayank Gupta | Director | 01-Oct-2024 | Current |
| Garima Sarawgi | Director | 12-Apr-2024 | Current |
Financial Performance of Pentaone Diagnostics.
Pentaone Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1217.27% increase. The company also saw a substantial fall in profitability, with a 7588.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2062.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pentaone Diagnostics?
Unlock access to Pentaone Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Shree Jagannath Infracon Private LimitedActive 15 years 10 months
Anil Gupta and Asha Gupta are mutual person
- Shree Chakanayan Agro Private LimitedActive 16 years 6 months
Asha Gupta and Sunil Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 May 2024 | ₹3.65 M | Open |
Others Creation Date: 10 May 2024 | ₹9.83 M | Open |
Others Creation Date: 16 Apr 2024 | ₹4.81 M | Open |
How Many Employees Work at Pentaone Diagnostics?
Pentaone Diagnostics has a workforce of 0 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pentaone Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pentaone Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
